Erste Asset Management’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-23,100	Closed	-$391K	–	787
2025 Q3	$391K	Sell	23,100 -62,000	-73%	-$764K	﹤0.01%	506
2025 Q2	$814K	Buy	85,100 +63,000	+285%	+$517K	0.01%	542
2025 Q1	$178K	Hold	22,100	–	–	﹤0.01%	479
2024 Q4	$265K	Hold	22,100	–	–	﹤0.01%	477
2024 Q3	$464K	Hold	22,100	–	–	0.01%	442
2024 Q2	$512K	Hold	22,100	–	–	0.01%	418
2024 Q1	$597K	Hold	22,100	–	–	0.01%	409
2023 Q4	$702K	Hold	22,100	–	–	0.01%	405
2023 Q3	$702K	Hold	22,100	–	–	0.01%	375
2023 Q2	$904K	Hold	22,100	–	–	0.02%	371
2023 Q1	$796K	Hold	22,100	–	–	0.02%	391
2022 Q4	$780K	Sell	22,100 -45	-0.2%	-$2.14K	0.02%	385
2022 Q3	$1.22M	Hold	22,145	–	–	0.03%	329
2022 Q2	$1.16M	Buy	22,145 +5,800	+35%	+$295K	0.03%	338
2022 Q1	$1.18M	Buy	16,345 +6,500	+66%	+$551K	0.02%	341
2021 Q4	$1.17M	Buy	9,845 +45	+0.5%	+$5.64K	0.02%	343
2021 Q3	$1.35M	Hold	9,800	–	–	0.03%	310
2021 Q2	$1.49M	Hold	9,800	–	–	0.03%	318
2021 Q1	$708K	Sell	9,800 -7,800	-44%	-$524K	0.02%	358
2020 Q4	$961K	Buy	+17,600	New	+$639K	0.03%	340
2019 Q1	–	Sell	-14,000	Closed	-$172K	–	748
2018 Q4	$172K	Buy	+14,000	New	+$260K	0.01%	377